Jubilant Pharmova Q2 Results
- BSE: 530019
- NSE: JUBLPHARMA
- ISIN: INE700A01033
- Sector: Biotechnology & Drugs
BSE
1,113.95
-27.25 (-2.39%)
-27.25 (-2.39%)Volume16.94 K
Updated: Mon 25 Nov, 2024 | 15:29:39
NSE
1,113-25.50 (-2.24%)
-25.50 (-2.24%)Volume2.28 L
Updated: Mon 25 Nov, 2024 | 15:29:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,752.30 Cr.(1.19%)
- Operating Profit₹183.80 Cr.(-66.98%)
- Profit After Tax₹102.80 Cr.(-78.68%)
- Operating Margin10.49%(21.38%)
Note: Comparison is on YoY basis
Quarterly - Jubilant Pharmova Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,752.30 | 1,586.90 | -% | 1,680.30 | -% |
| Selling/ General/ Admin Expenses Total | 564.30 | 547.70 | -% | 531.80 | -% |
| Depreciation/ Amortization | 91.40 | 89.70 | -% | 96.60 | -% |
| Other Operating Expenses Total | 343.80 | 349.50 | -% | 349.40 | -% |
| Total Operating Expense | 1,568.50 | 1,507.00 | -% | 1,535.10 | -% |
| Operating Income | 183.80 | 79.90 | -% | 145.20 | -% |
| Net Income Before Taxes | 144.40 | 25.20 | -% | 98.00 | -% |
| Net Income | 102.80 | 6.40 | -% | 62.50 | -% |
| Diluted Normalized EPS | 7.09 | 0.40 | -% | 3.94 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST